HIGHER Corporation Recognized as 'Baby Unicorn' for Innovative Medical Devices
HIGHER Corporation's selection as a 'Baby Unicorn' underscores its potential in the global medical device market, with its HILO WAVE® product leading the charge in innovative skin regeneration technology.
HIGHER Corporation, a pioneering medical device startup, has been distinguished as a 'Baby Unicorn' by the Ministry of SMEs and Startups, alongside receiving the 'First Penguin' accolade from the Korea Credit Guarantee Fund. These recognitions affirm the company's cutting-edge technology and robust business model, positioning it as a future global unicorn in the medical device sector.
The 'Baby Unicorn' initiative is a strategic government effort to foster startups with high global growth potential. Through customized support and funding, the program accelerates the development of innovative companies. HIGHER Corporation's inclusion in this elite group highlights its significant contributions to the Korean startup ecosystem and its potential to influence the global aesthetic medical device market.
At the heart of HIGHER Corporation's success is HILO WAVE®, a revolutionary collagen booster that utilizes a dual-formulation of hyaluronic acid to enhance skin elasticity and hydration naturally. Approved as a Class 4 medical device in Korea, HILO WAVE® stands out for its ability to stimulate the skin's regeneration process, offering immediate and lasting results.
The company's global ambitions are evident in its substantial supply contracts across Southeast Asia and ongoing negotiations in Brazil and China, with potential deals exceeding 20 billion KRW. Plans for CE MDR certification further underscore HIGHER Corporation's commitment to expanding its footprint in the European market, reinforcing its status as a key player in the international aesthetic medical device industry.
With the backing of the Ministry of SMEs and Startups, including financial support and market development opportunities, HIGHER Corporation is poised to solidify its presence in both domestic and international markets. The company's innovative approach and strategic global partnerships herald a new era of growth and innovation in the medical device sector.